Processing

Please wait...

Settings

Settings

Goto Application

1. WO1998035968 - REMEDIES/PREVENTIVES FOR RESPIRATORY DISEASES

Publication Number WO/1998/035968
Publication Date 20.08.1998
International Application No. PCT/JP1997/004878
International Filing Date 26.12.1997
Chapter 2 Demand Filed 28.07.1998
IPC
A61K 31/519 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
519ortho- or peri-condensed with heterocyclic rings
C07D 487/14 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
487Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/-C07D477/183
12in which the condensed system contains three hetero rings
14Ortho-condensed systems
CPC
A61K 31/519
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495having six-membered rings with two ; or more; nitrogen atoms as the only ring heteroatoms, e.g. piperazine ; or tetrazines
505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
519ortho- or peri-condensed with heterocyclic rings
A61P 11/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
11Drugs for disorders of the respiratory system
A61P 11/08
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
11Drugs for disorders of the respiratory system
08Bronchodilators
C07D 487/14
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
487Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
12in which the condensed system contains three hetero rings
14Ortho-condensed systems
Applicants
  • POLA CHEMICAL INDUSTRIES, INC. [JP]/[JP] (AllExceptUS)
  • NAMIKI, Takayuki [JP]/[JP] (UsOnly)
  • YUASA, Masayuki [JP]/[JP] (UsOnly)
  • TAKAKUWA, Takako [JP]/[JP] (UsOnly)
  • ICHINOMIYA, Satoshi [JP]/[JP] (UsOnly)
  • TAMAI, Masashi [JP]/[JP] (UsOnly)
  • HIYAMA, Naoki [JP]/[JP] (UsOnly)
  • KAWAZU, Yukio [JP]/[JP] (UsOnly)
  • YAHIRO, Tomoaki [JP]/[JP] (UsOnly)
  • SUGIO, Mayumi [JP]/[JP] (UsOnly)
Inventors
  • NAMIKI, Takayuki
  • YUASA, Masayuki
  • TAKAKUWA, Takako
  • ICHINOMIYA, Satoshi
  • TAMAI, Masashi
  • HIYAMA, Naoki
  • KAWAZU, Yukio
  • YAHIRO, Tomoaki
  • SUGIO, Mayumi
Agents
  • ARUGA, Mitsuyuki
Priority Data
9/4719714.02.1997JP
9/4721114.02.1997JP
Publication Language Japanese (JA)
Filing Language Japanese (JA)
Designated States
Title
(EN) REMEDIES/PREVENTIVES FOR RESPIRATORY DISEASES
(FR) PRODUITS THERAPEUTIQUES/PROPHYLACTIQUES DES MALADIES RESPIRATOIRES
Abstract
(EN)
Remedies/preventives for respiratory diseases containing as the active ingredient compounds represented by general formula (1) or salts thereof: (1)(wherein R1 represents linear, branched or cyclic C1-10 alkyl; and R2 represents hydrogen, halogeno, substituted alkyl, optionally substituted amino, carboxy, alkoxycarbonyl, carbamoyl or alkylcarbamoyl). These compounds have excellent bronchodilating and respiratory tract contraction-inhibitory effects.
(FR)
L'invention concerne des produits thérapeutiques/prophylactiques des maladies respiratoires. Ces produits contiennent comme ingrédients actifs, des composés représentés par la formule générale (1) ou des sels de ces derniers. Dans la formule, R1 représente un alkyle C1-10 cyclique, ramifié ou linéaire; et R2 représente de l'hydrogène, de l'halogéno, de l'alkyle substitué, de l'amino éventuellement substitué, du carboxy, de l'alcoxycarbonyle, du carbamoyle ou de l'alkylcarbamoyle). Ces composés présentent d'excellents effets bronchodilatateurs et inhibiteurs de la contraction du système respiratoire.
Latest bibliographic data on file with the International Bureau